1. aBuettelmann, B.; Ceccarelli, S.; Jaeschke, G.; Kolczewski, S.; Porter, R.; Spurr, P.; Vieira, E.Imidazole Derivatives. U.S. Pat. Appl. U.S. 20050054686, 2005; CAN142:298113
2. bBuettelmann, B.; Ceccarelli, S.; Jaeschke, G.; Kolczewski, S.; Porter, R.; Spurr, P.; Vieira, E.Preparation of pyridin-4-ylethynylimidazoles and -pyrazoles as mGluR5a receptor antagonists.PCT Int. Appl.WO/2005118568, 2005; CAN144:51579
3. cBuettelmann, B.; Ceccarelli, S.; Jaeschke, G.; Kolczewski, S.; Porter, R.; Vieira, E.Preparation of (1H-imidazol-4-yl)ethynylpyridines as metabotropic glutamate 5 receptor antagonists for treating neurodegenerative diseases, in particular anxiety.PCT Int. Appl.WO/2004080998, 2004; CAN141:296020
4. dBuettelmann, B.; Ceccarelli, S.; Jaeschke, G.; Kolczewski, S.; Porter, R.; Vieira, E.A preparation of (pyridin-4-ylethynyl)imidazole derivatives, useful for the treatment of mGluR5 receptor mediated disorders. U.S. Pat. Appl. U.S. 2004248888, 2004; CAN142:23285
5. eBuettelmann, B.; Ceccarelli, S.; Jaeschke, G.; Kolczewski, S.; Philip, P.; Vieira, E.; Ford, A.; Zhong, Y.A preparation of (pyridin-4-ylethynyl)imidazole derivatives, useful for the treatment of mGluR5 receptor mediated disorders. U.S. Pat. Appl. U.S. 2005143375, 2005; CAN173:78185